Afghanistan - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Afghanistan Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases jumped by 40.7% year on year. With 486 Cases in 2019, the country was number 70 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. Afghanistan is overtaken by Angola, which was number 69 at 505 Cases and is followed by Romania with 455 Cases. India topped the ranking with 66,255 Cases in 2019, that is +13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 486.00 |
| 2018 | 452.00 |
| 2017 | 279.00 |
| 2016 | 153.00 |
| 2015 | 81.00 |
How does Afghanistan rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 67 |
#67
Kenya
|
507 | 2019 | +9.0 % | -4.7 % | View data | |
| 70 |
#70
Afghanistan
|
486 | 2019 | +7.5 % | +40.7 % | View data | |
| 71 |
#71
Romania
|
455 | 2019 | -2.4 % | -4.7 % | View data | |